Cas 185147-44-8,Sodium 2-(4-fluorophenyl)-3-((4-methylsulfonyl)phenyl)-4-oxo-2-pentenoate

185147-44-8

Post Buying Request

Basic information

Product Name: Sodium 2-(4-fluorophenyl)-3-((4-methylsulfonyl)phenyl)-4-oxo-2-pentenoate
Synonyms: Sodium 2-(4-fluorophenyl)-3-((4-methylsulfonyl)phenyl)-4-oxo-2-pentenoate
CAS NO:185147-44-8
Molecular Formula:
Molecular Weight: 384.36
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Sodium 2-(4-fluorophenyl)-3-((4-methylsulfonyl)phenyl)-4-oxo-2-pentenoate(CAS DataBase Reference)
NIST Chemistry Reference: Sodium 2-(4-fluorophenyl)-3-((4-methylsulfonyl)phenyl)-4-oxo-2-pentenoate(185147-44-8)
EPA Substance Registry System: Sodium 2-(4-fluorophenyl)-3-((4-methylsulfonyl)phenyl)-4-oxo-2-pentenoate(185147-44-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 185147-44-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

185147-44-8 Suppliers

Recommended suppliers

185147-44-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 185147-44-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,5,1,4 and 7 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 185147-44:
(8*1)+(7*8)+(6*5)+(5*1)+(4*4)+(3*7)+(2*4)+(1*4)=148
148 % 10 = 8
So 185147-44-8 is a valid CAS Registry Number.

185147-44-8Upstream product

185147-20-0 3-(4-Fluorophenyl)-5-hydroxy-5-methyl-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone

185147-44-8Downstream Products

185147-44-8Relevant academic research and scientific papers

Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors

-

, (2008/06/13)

The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. STR1 The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 185147-44-8